Connect with us

Health

A look at COVID-19 vaccinations in Canada on Mar. 13, 2021 – Burnaby Now

Published

 on


The latest numbers on COVID-19 vaccinations in Canada as of 4:00 a.m. ET on Saturday, March 13, 2021.

In Canada, the provinces are reporting 95,261 new vaccinations administered for a total of 2,814,488 doses given. Nationwide, 590,192 people or 1.6 per cent of the population has been fully vaccinated. The provinces have administered doses at a rate of 7,426.231 per 100,000.

There were no new vaccines delivered to the provinces and territories for a total of 3,227,410 doses delivered so far. The provinces and territories have used 87.21 per cent of their available vaccine supply.

<i>Please note that Newfoundland, P.E.I., Nova Scotia, New Brunswick and the territories typically do not report on a daily basis.</i>

<b>Newfoundland</b> is reporting 8,864 new vaccinations administered over the past seven days for a total of 33,621 doses given. The province has administered doses at a rate of 64.207 per 1,000. In the province, 1.75 per cent (9,170) of the population has been fully vaccinated. There were zero new vaccines delivered to Newfoundland for a total of 48,470 doses delivered so far. The province has received enough of the vaccine to give 9.3 per cent of its population a single dose. The province has used 69.36 per cent of its available vaccine supply.

<b>P.E.I.</b> is reporting 1,945 new vaccinations administered over the past seven days for a total of 15,226 doses given. The province has administered doses at a rate of 95.985 per 1,000. In the province, 3.52 per cent (5,584) of the population has been fully vaccinated. There were zero new vaccines delivered to P.E.I. for a total of 15,885 doses delivered so far. The province has received enough of the vaccine to give 10 per cent of its population a single dose. The province has used 95.85 per cent of its available vaccine supply.

<b>Nova Scotia</b> is reporting 8,215 new vaccinations administered over the past seven days for a total of 46,891 doses given. The province has administered doses at a rate of 48.049 per 1,000. In the province, 1.60 per cent (15,655) of the population has been fully vaccinated. There were zero new vaccines delivered to Nova Scotia for a total of 73,680 doses delivered so far. The province has received enough of the vaccine to give 7.5 per cent of its population a single dose. The province has used 63.64 per cent of its available vaccine supply.

<b>New Brunswick</b> is reporting 4,742 new vaccinations administered over the past seven days for a total of 38,483 doses given. The province has administered doses at a rate of 49.335 per 1,000. In the province, 1.56 per cent (12,152) of the population has been fully vaccinated. There were zero new vaccines delivered to New Brunswick for a total of 56,135 doses delivered so far. The province has received enough of the vaccine to give 7.2 per cent of its population a single dose. The province has used 68.55 per cent of its available vaccine supply.

<b>Quebec</b> is reporting 29,603 new vaccinations administered for a total of 648,663 doses given. The province has administered doses at a rate of 75.808 per 1,000. There were zero new vaccines delivered to Quebec for a total of 825,065 doses delivered so far. The province has received enough of the vaccine to give 9.6 per cent of its population a single dose. The province has used 78.62 per cent of its available vaccine supply.

<b>Ontario</b> is reporting 43,503 new vaccinations administered for a total of 1,062,910 doses given. The province has administered doses at a rate of 72.361 per 1,000. In the province, 1.92 per cent (282,748) of the population has been fully vaccinated. There were zero new vaccines delivered to Ontario for a total of 1,086,745 doses delivered so far. The province has received enough of the vaccine to give 7.4 per cent of its population a single dose. The province has used 97.81 per cent of its available vaccine supply.

<b>Manitoba</b> is reporting 1,699 new vaccinations administered for a total of 99,482 doses given. The province has administered doses at a rate of 72.245 per 1,000. In the province, 2.28 per cent (31,464) of the population has been fully vaccinated. There were zero new vaccines delivered to Manitoba for a total of 159,220 doses delivered so far. The province has received enough of the vaccine to give 12 per cent of its population a single dose. The province has used 62.48 per cent of its available vaccine supply.

<b>Saskatchewan</b> is reporting 2,692 new vaccinations administered for a total of 98,571 doses given. The province has administered doses at a rate of 83.595 per 1,000. In the province, 2.44 per cent (28,771) of the population has been fully vaccinated. There were zero new vaccines delivered to Saskatchewan for a total of 93,145 doses delivered so far. The province has received enough of the vaccine to give 7.9 per cent of its population a single dose. The province has used 105.8 per cent of its available vaccine supply.

<b>Alberta</b> is reporting 15,805 new vaccinations administered for a total of 333,379 doses given. The province has administered doses at a rate of 75.733 per 1,000. In the province, 2.08 per cent (91,470) of the population has been fully vaccinated. There were zero new vaccines delivered to Alberta for a total of 326,445 doses delivered so far. The province has received enough of the vaccine to give 7.4 per cent of its population a single dose. The province has used 102.1 per cent of its available vaccine supply.

<b>British Columbia</b> is reporting zero new vaccinations administered for a total of 366,791 doses given. The province has administered doses at a rate of 71.477 per 1,000. In the province, 1.70 per cent (87,024) of the population has been fully vaccinated. There were zero new vaccines delivered to British Columbia for a total of 445,920 doses delivered so far. The province has received enough of the vaccine to give 8.7 per cent of its population a single dose. The province has used 82.25 per cent of its available vaccine supply.

<b>Yukon</b> is reporting zero new vaccinations administered for a total of 26,374 doses given. The territory has administered doses at a rate of 632.00 per 1,000. In the territory, 22.17 per cent (9,253) of the population has been fully vaccinated. There were zero new vaccines delivered to Yukon for a total of 35,000 doses delivered so far. The territory has received enough of the vaccine to give 84 per cent of its population a single dose. The territory has used 75.35 per cent of its available vaccine supply.

<b>The Northwest Territories</b> are reporting zero new vaccinations administered for a total of 28,208 doses given. The territory has administered doses at a rate of 625.191 per 1,000. In the territory, 24.71 per cent (11,151) of the population has been fully vaccinated. There were zero new vaccines delivered to the Northwest Territories for a total of 35,300 doses delivered so far. The territory has received enough of the vaccine to give 78 per cent of its population a single dose. The territory has used 79.91 per cent of its available vaccine supply.

<b>Nunavut</b> is reporting 217 new vaccinations administered for a total of 15,889 doses given. The territory has administered doses at a rate of 410.293 per 1,000. In the territory, 14.85 per cent (5,750) of the population has been fully vaccinated. There were zero new vaccines delivered to Nunavut for a total of 26,400 doses delivered so far. The territory has received enough of the vaccine to give 68 per cent of its population a single dose. The territory has used 60.19 per cent of its available vaccine supply.

<sup>*</sup>Notes on data: <i>The figures are compiled by the COVID-19 Open Data Working Group based on the latest publicly available data and are subject to change. Note that some provinces report weekly, while others report same-day or figures from the previous day. Vaccine doses administered is not equivalent to the number of people inoculated as the approved vaccines require two doses per person. The vaccines are currently not being administered to children under 18 and those with certain health conditions. In some cases the number of doses administered may appear to exceed the number of doses distributed as some provinces have been drawing extra doses per vial.</i>

This report was automatically generated by The Canadian Press Digital Data Desk and was first published March 13, 2021.

The Canadian Press

Let’s block ads! (Why?)



Source link

Continue Reading

Health

Canada will not restrict AstraZeneca COVID-19 vaccine, says benefits outweigh risk

Published

 on

OTTAWA (Reuters) – Canada‘s health ministry said on Wednesday it would not restrict use of AstraZeneca Plc’s COVID-19 vaccine after a review showed the benefits outweighed the very rare risk of blood clots.

A separate advisory council had earlier recommended Canada stop offering the vaccine to people under 55. The panel is now reviewing that advice, the health ministry said in a statement.

Denmark on Wednesday became the first country to stop using the vaccine altogether over a potential link to the rare blood clots. Other nations have imposed limits on its use.

But Health Canada, the federal health ministry, said in a statement that a review of data from Europe, Britain and AstraZeneca had not identified specific risk factors.

“Therefore, Health Canada is not restricting the use of the vaccine in any specific populations at this time … The potential risk of these events is very rare, and the benefits of the vaccine in protecting against COVID-19 outweigh its potential risks,” it said.

Canada on Tuesday said it had recorded its first case of blood clotting with low platelets after someone received the AstraZeneca shot. The patient in question, a woman from Quebec, is recovering. (Graphic on vaccines: https://tmsnrt.rs/3tUM8ta)

COVID-19 cases are surging in Canada with the country reporting a near-record number of new cases recently. (Graphic on cases: https://tmsnrt.rs/34pvUyi)

 

(Reporting by David Ljunggren in Ottawa and Allison Martell in Toronto; Editing by Lisa Shumaker)

Continue Reading

Health

Factbox-Some countries limit AstraZeneca vaccine use, US pauses J&J shot

Published

 on

(Reuters) -Some countries are restricting use of the AstraZeneca COVID-19 vaccine to certain age groups or suspending use after European and British regulators confirmed possible links to rare blood clots.

Denmark became the first country to stop using the vaccine altogether, as it said results of investigations showed “real and serious side-effects”.

Johnson & Johnson’s single-shot vaccine has also been hit by concerns over blood clots, with European regulators reviewing such cases and U.S. federal health agencies recommending pausing its use for a few days. J&J noted no clear causal relationship had been established between the clots and its vaccine.

The developments pose a risk to vaccination plans in Europe.

Regulators have said the benefits of the AstraZeneca shot outweigh risks.

Anglo-Swedish drugmaker AstraZeneca said it was working with regulators to list the possible brain blood clots as “an extremely rare potential side effect” on the vaccines labels.

As of April 4, the European Medicines Agency had received reports of 169 cases of a rare brain blood clot known as cerebral venous sinus thrombosis (CVST), after 34 million doses had been administered in the European Economic Area. Most cases were in women under 60 years of age.

ASTRAZENECA VACCINE BEING USED, WITH OR WITHOUT RESTRICTIONS

AUSTRALIA

Said on April 8 it recommends people under 50 should get Pfizer’s COVID-19 vaccine in preference to AstraZeneca’s shot.

AUSTRIA

Has resumed use.

BRAZIL

Authorities said they would not limit use of the AstraZeneca vaccine, saying benefits outweigh risks.

BRITAIN

The Joint Committee on Vaccination and Immunisation has said an alternative to the vaccine should be given for people under 30 where possible, but people should continue to have a second shot if they have received a first dose.

BULGARIA

Resumed inoculations from March 19.

CYPRUS

Resumed inoculations on March 19.

CANADA

Authorities said in early April they would pause offering the vaccine to people under 55 and require a new analysis of the shot’s benefits and risks based on age and gender. On April 13, the country said it had recorded its first case of blood clotting with low platelets.

ESTONIA

Suspended use of the vaccine for people under 60 on April 7.

FRANCE

Approved resumption of the vaccine on March 19 but said it should be given only to people aged 55 and over. On April 9, recommended that recipients of a first dose of the AstraZeneca shot who are under 55 should receive a second dose with a messenger RNA vaccine.

FINLAND

Resumed using the AstraZeneca vaccine from March 29, but only for people aged 65 and over.

GEORGIA

Has limited use of the vaccine following the death of a nurse from anaphylactic shock, and vaccinations will continue only in full-fledged medical centres, Russian news agency TASS reported on March 19.

GERMANY

Sticking to its guidance from March 31 to limit use of the vaccine to those aged over 60. On April 1, Germany’s vaccine commission recommended people under 60 who have had a first shot of the vaccine should receive a different product for their second dose.

HUNGARY

Continuing the vaccine’s rollout.

ICELAND

Resumed use on March 25 after suspending it on March 11.

INDONESIA

Resumed using the vaccine on March 22 but warned against its use in people with a low blood platelet count.

IRELAND

On April 12, the country said it was restricting use of the vaccine to those over 60.

ITALY

Has recommended the vaccine be used only for people over 60, the country’s top health adviser said.

LATVIA

Announced it was restarting administering the shots from March 19.

LITHUANIA

Restarted use on March 19.

MEXICO

Drug regulator Cofepris said on April 7 it did not “at this time” plan to limit the vaccine’s use but was investigating the information raised by Britain.

NETHERLANDS

Limited use of the vaccine to people over 60, the Dutch government said on April 8.

NORTH MACEDONIA

Health minister said on March 31 the vaccine would be limited to people aged over 60 as a precautionary measure.

PHILIPPINES

Suspended use of the vaccine for people under 60 on April 8.

ROMANIA

Has resumed use of the vaccine after temporarily stopping vaccinating people with one batch of the vaccine on March 11.

SOUTH KOREA

Resumed use of the shot for people aged 30 or older on April 12. On April 7, it had suspended providing the AstraZeneca shot to people under 60.

SPAIN

From April 8, it was giving the vaccine only to people over 60.

SWEDEN

Resumed use of the vaccine on March 25 for people aged 65 and older.

THAILAND

Began use on March 15 after delaying rollout the week before.

COUNTRIES WHERE ASTRAZENECA VACCINE USE SUSPENDED

CAMEROON

Suspended administration of the vaccine it was scheduled to receive on March 20 as part of the global vaccines sharing scheme COVAX, the health ministry said.

DENMARK

In a world first, Denmark decided to stop using the AstraZeneca vaccine altogether after initially suspending use of the shot.

NORWAY

Authorities said on March 26 Norway would delay a decision on use of the vaccine, with a decision expected by April 15.

J&J VACCINE DELAYS AND RESTRICTIONS

UNITED STATES

On April 13, U.S. federal health agencies recommended pausing use of J&J’s COVID-19 vaccine for at least a few days after six women under the age of 50 developed rare blood clots after receiving the shot.

EUROPEAN UNION

The company said it would delay the rollout of the vaccine to Europe, after regulators said they were reviewing rare blood clots.

Widespread use in the EU had not yet started after the company began delivering the doses in the week beginning April 12. The European drug regulator recommended storing doses already received until its safety committee issues an expedited recommendation

SOUTH AFRICA

Suspended use of J&J’s vaccine on April 13.

(Reporting by Pushkala Aripaka, Yadarisa Shabong, Manas Mishra, Vishwadha Chander, Amruta Khandekar and Mrinalika Roy in Bengaluru; editing by Josephine Mason, Alison Williams, Timothy Heritage, Larry King, Barbara Lewis)

Continue Reading

Health

Ontario hospitals may have to withhold care as COVID-19 fills ICUs

Published

 on

By Allison Martell and Anna Mehler Paperny

TORONTO (Reuters) – Doctors in the Canadian province of Ontario may soon have to decide who can and cannot receive treatment in intensive care as the number of coronavirus infections sets records and patients are packed into hospitals still stretched from a December wave.

Canada‘s most populous province is canceling elective surgeries, admitting adults to a major children’s hospital and preparing field hospitals after the number of COVID-19 patients in ICUs jumped 31% to 612 in the week leading up to Sunday, according to data from the Ontario Hospital Association.

The sharp increase in Ontario hospital admissions is also straining supplies of tocilizumab, a drug often given to people seriously ill with COVID-19.

Hospital care is publicly funded in Canada, generally free at the point of care for residents. But new hospital beds have not kept pace with population growth, and shortages of staff and space often emerge during bad flu seasons.

Ontario’s hospitals fared relatively well during the first wave of the pandemic last year, in part because the province quickly canceled elective surgeries.

The College of Physicians and Surgeons of Ontario told doctors last Thursday that the province was considering “enacting the critical care triage protocol,” something that was not done during earlier waves of the virus. Triage protocols help doctors decide who to treat in a crisis.

“Everybody’s under extreme stress,” said Eddy Fan, an ICU doctor at Toronto’s University Health Network. He said no doctor wants to contemplate a triage protocol but there are only so many staff.

“There’s going to be a breaking point, a point at which we can’t fill those gaps any longer.”

In a statement, the health ministry said Ontario has not activated the protocol. A September draft suggested doctors could withhold life-sustaining care from patients with a less than 20% chance of surviving 12 months. A final version has not been made public.

Ontario’s Science Advisory Table had been forecasting the surge for months, said member and critical care physician Laveena Munshi. During a recent shift she wanted to call the son of a patient only to discover he was in an ICU across the street.

“The horror stories that we’re seeing in the hospital are like ones out of apocalyptic movies,” she said. “They’re not supposed to be the reality we’re seeing one year into a pandemic.”

Continue Reading

Trending